# ClearPoint Neuro Reports First Quarter 2026 Results
Canonical URL: https://biopharmsignal.com/news/CLPT/clearpoint-neuro-reports-first-quarter-2026-results
Ticker: CLPT
Company: ClearPoint Neuro
Source: ClearPoint Neuro
Published: 2026-05-13 20:05 EST
Original Source URL: https://ir.clearpointneuro.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-27 20:30 EST — [ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-enters-into-10-year-focused-ultrasound-development-partnership-with-sungkyunkwan-university-south-korea-further-expanding-our-drug-delivery-ecosystem-and-global-footprint) — Source: ClearPoint Neuro
- 2026-05-13 20:05 EST — [ClearPoint Neuro Reports First Quarter 2026 Results](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-reports-first-quarter-2026-results) — Source: ClearPoint Neuro
- 2026-05-13 20:00 EST — [ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-announces-ce-marking-of-velocity-alpha-mr-high-speed-surgical-drill-system-further-expanding-drug-delivery-ecosystem-and-global-footprint) — Source: ClearPoint Neuro
- 2026-04-29 20:05 EST — [ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-first-quarter-2026-results-may-13-2026) — Source: ClearPoint Neuro
- 2026-04-22 20:05 EST — [ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alpha-r-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint) — Source: ClearPoint Neuro
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)